-
Mashup Score: 2
Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; discuss the current landscape and treatment of Dry Eye Disease.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; discuss the current landscape and treatment of Dry Eye Disease.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; discuss the current landscape and treatment of Dry Eye Disease.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Highlights from the TFOS Lifestyle Reports - 8 month(s) ago
An interview with Christopher Starr, MD By Christine Yue Leonard, Senior Associate Editor D ry eye has a profound effect on quality of life. While we have a full armamentarium of treatments to offer patients, we can’ t always account for the impact of certain day-to-day lifestyle choices or situations when managing this chronic and often debilitating disease. Patients often want to know what else they can do to get through each day, in addition to the dry-eye treatments provided by their eye-care provider.
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Dry Eye | National Eye Institute - 9 month(s) ago
Dry eye happens when your eyes don’t make enough tears to stay wet. Learn about the symptoms, causes, diagnosis, and treatment of dry eye.
Source: www.nei.nih.govCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0ASCRS Preoperative OSD Algorithm - 10 month(s) ago
Optimize Your OSD Treatment The new ASCRS Preoperative OSD Algorithm developed by the ASCRS Cornea Clinical Committee provides surgeons in busy surgical practices with an easy-to-use framework for diagnosing and treating OSD. With this tool, surgeons can address OSD as part of the process for evaluating presurgical patients. Explore educational resources surrounding this…
Source: ascrs.orgCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0A Look at the Dry-Eye Treatment Pipeline - 10 month(s) ago
As the prevalence of dry eye continues to grow, so does the need for effective therapies. There are a number of new therapeutic approaches in development for the management of this condition that could help improve outcomes and quality of life for these patients. Here, we’ll take a closer look at these agents and where they currently stand in the developmental process. Reproxalap (Aldeyra)This…
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0A Look at the Dry-Eye Treatment Pipeline - 10 month(s) ago
As the prevalence of dry eye continues to grow, so does the need for effective therapies. There are a number of new therapeutic approaches in development for the management of this condition that could help improve outcomes and quality of life for these patients. Here, we’ll take a closer look at these agents and where they currently stand in the developmental process. Reproxalap (Aldeyra)This…
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1Week in review: Firearms-related ocular injuries, AMD and heart disease, new dry eye treatment - 11 month(s) ago
Rates of advanced trauma care for firearms-related ocular injuries vary by age and race, visual disabilities increase the risk of cardiovascular disease in patients with AMD, and MIEBO, a new treatmen
Categories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0IPL-RF Combination Effective for Dry Eyes in Small Study - 12 month(s) ago
The study evaluated the effects of intense pulsed light with topical radiofrequency in 11 patients with dry eye disease related to meibomian gland dysfunction.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
In this Stakeholder Summit, experts discuss navigating different subtypes of #dryeye disease (DED), such as ocular surface disease, and the efficacy of treatment through patient-reported outcomes. Watch the episodes here: https://t.co/25CzNWE6iz https://t.co/kgkPIBmtEU